Cell-mediated immunity to Toxoplasma gondii: Initiation, regulation and effector function

Immunobiology

Volumn 201, Issue 2, 1999, Pages 240-247

  Yap, George S ^a   Sher, Alan ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; HEMATOPOIETIC CELL; NATURAL KILLER CELL; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; T LYMPHOCYTE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0032762620     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(99)80064-3     Document Type: Conference Paper

References (28)

1. SUZUKI, Y., F. K. CONLEY, and J. S. REMINGTON. 1989. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143: 2045-2050.
2. SCHARTON-KERSTEN, T. M., T. A. WYNN, E. Y. DENKERS, S. BALA, E., GRUNVALD, S. HIENY; R. T. GAZZINELLI, and A. SHER. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157: 4045-54.
3. GAZZINELLI, R. T., Y. XU, S. HIENY, A. CHEEVER, and A. SHER. 1992. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149: 175-180.
4. GAZZINELLI, R. T., I. A. ELTOUM, T. WYNN, and A. SHER. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151: 3672-3681.
5. DECKERT-SCHLUTER, M., H. BLUETHMANN, A. RANG, H. HOF, and D. SCHLUTER. 1998. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J. Immunol. 160: 3427-3436.
6. YAP, G. S., T. SCHARTON-KERSTEN, H. CHAREST, and A. SHER. 1998. Decreased resistance of TNF receptor p55 and p75 deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J. Immunol. 160: 1340-1345.
7. BIRON, C. A., and R. T. GAZZINELLI. 1995. Effects of IL-12 on immune responses to microbial infection: a key mediator in regulating disease outcome. Curr. Opinion Immunol. 7: 485-496.
8. GAZZINELLI, R. T. M. WYSOCKA, S. HAYASHI, E. DENKERS, S. HIENY, P. CASPAR, G. TRINCHIERI, and A. SHER. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153: 2533-2543.
9. SCHARTON-KERSTEN, T. M., G. YAP, J. MAGRAM, and A. SHER. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185: 1261-73.
10. TRIPP, C. S., O. KANAGAWA, and E. R. UNANUE. 1995. Secondary response to Listeria monocytogenes infection requires IFN-γ but is partially independent of IL-12. J. Immunol. 155: 3427-3432.
11. ZHOU, P., G. MILLER, and R. A. SEDER. 1998. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. J. Immunol. 160: 1359-1368.
12. REIS E SOUSA, C., S. HIENY, T. SCHARTON-KERSTEN, D. JANKOVIC, H. CHAREST, R. N. GERMAIN, and A. SHER. 1997. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186: 1819-1829.
13. MALDONADO-LOPEZ, R., T. DE SMEDT, P. MICHEL, J. GODFROID, B. PAJAK, C. HEIRMAN, K. THIELEMANS, O. LEO, J. URBAIN, and M. MOSER. 1999. CD8α+ and CD8α-subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-592.
14. BOURGUIN, I., M. MOSER, D. BUZONI, GATEL, F. TIELEMANS, D. BOUT, J. URBAIN, and O. LEO. 1998. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect. Immun. 66: 4867-4874.
15. GAZZINELLI, R. T., M. WYSOCKA, S. HIENY, T. SCHARTON-KERSTEN, A. CHEEVER, R. KUHN, W. MULLER, G. TRINCHIERI, and A. SHER. 1996. In the absence of endogenous Il-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4 T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 157: 798-805.
16. NEYER, L. E., G. GRUNIG, M. FORT, J. S. REMINGTON, D. RENNICK, and C. A. HUNTER. 1997. Role of interleukin-10 in regulation of T cell-dependent and T cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65: 1675-1682.
17. CHINCHILLA, M., and J. K. FRENKEL. 1978. Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells. Infect. Immun. 19: 999-1012.
18. REMINGTON, J. S., and T. C. MERIGAN. 1968. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science 161: 804-806.
19. REMINGTON, J. S., J. L. KRAHENBUHL, and J. W. MENDENHALL. 1972. A role for activated macrophages in resistance to infection with Toxoplasma. Infect. Immun. 6: 829-834.
20. GAZZINELLI, R. T., E. Y. DENKERS, and A. SHER. 1993. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity to intracellular parasites. Infect. Agents Dis. 2: 139-149.
21. KAUFMANN, S. H. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11: 129-163.
22. YAMASHITA, K., K. YUI, M. UEDA, and A. YANO. 1998. Cytotoxic T-lymphocyte-mediated lysis of Toxoplasma gondii infected target cells does not lead to death of intracellular parasites. Infect. Immun. 66: 4651-4655.
23. DENKERS, E. Y., G. YAP, T. SCHARTON-KERSTEN, H. CHAREST, B. A. BUTCHER, P. CASPAR, S. HEINY, and A. SHER. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J. Immunol. 159: 1903-1908.
24. YAP, G. S., and A. SHER. 1999. Effector cells of both non-hemopoietic and hemopoietic origin are required for interferon (IFN)-γ-and tumor necrosis factor (TNF)-α-dependent host resistance to Toxoplasma gondii. J. Exp. Med. 189: 1083-1091.
25. ENDRES, R., A. LUZ, H. SCHULZE, H. NEUBAUER, A. FUTTERER, S. M. HOLLAND, H. WAGNER, and K. PFEFFER. 1997. Listeriosis in p47 (phox -/-) and TNF R p55 -/-mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 7: 419-432.
26. CHAO, C. C., W. R. ANDERSON, S. HU, G. GEKKER, A. MARTELLA, and P. K. PETERSON. 1993. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol. 67: 178-183.
27. KHAN, I. A., T. MATSUURA, and L. H. KASPER. 1998. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii. J. Immunol. 161: 2994-3000.
28. HALONEN, S. K., F. C. CHIU, and L. M. WEISS. 1998. Effect of cytokines on growth of Taxoplasma gondii in murine astrocytes. Infect. Immun. 66: 4989-4993.